cuvette.bio / experiments as infrastructure

Ask the question.
The wet lab answers.

Cuvette makes an API call from human curiosity to a cloud lab. Your hypothesis is compiled, run on shared automated infrastructure, and returned as experimental evidence.

No instrument purchase. No laboratory build.

Hypothesis → API → cloud lab → evidence Proposed workflow

01 / Human intuition

“Could selective HDAC6 inhibition improve Treg function?”

A question worth testing—not a lab to build.

02 / Cuvette API

{ C }

Compile · route · QC

protocol spec
lab route
QC contract

03 / Cloud lab

Shared, automated wet-lab infrastructure

A specialized CRO or centralized lab executes the work.

04 / Human evidence

Experimental validation

Results, negative findings, methods and a complete QC trail return to the researcher.

Evidence returns to the person who askedCuriosity stays human. Infrastructure becomes a utility.

The instrument

Write the question. Inspect the experiment.

The compiler keeps scientific intent legible while turning it into a protocol an independent professional lab can execute and return against explicit quality criteria.

Hypothesis compiler / live sequence Accepting input

Natural language input

Wayne · retired immunology pioneer

Standardized experiment protocolWaiting

ROUTE / matched execution partnerRETURN / data + metadata + QC trail

Route ticket

Capability matched

workflow / immunology screen
criteria / capacity + method fit
provider / independent lab
status / ready for review

QC contract

Checks travel with the job

controls / pre-registered
metadata / required
acceptance / explicit
changes / deviation log

Evidence package

Nothing useful is discarded

raw files / included
negative results / retained
methods / versioned
chain of custody / complete

01 / The operating model

The lab network becomes programmable.

Biology still behaves as if access to an instrument and access to an answer are the same thing. Cuvette separates them. It is the orchestration layer above CROs and automated labs: a common interface for designing work, matching it to capacity, and making the output comparable.

01 —

Design

State the hypothesis in plain language or through the API. Scientific intent stays legible to the researcher, rather than disappearing into procurement or bespoke handoffs.

02 —

Compile

Translate intent into a standardized, machine-executable protocol: methods, controls, acceptance criteria, metadata requirements and an auditable data schema.

03 —

Execute

Route each workflow to the right independent execution partner. CROs and automated labs—labs like Medra or Ginkgo, illustratively—provide the hands; Cuvette provides the common language. No partnership or integration is implied.

04 —

Return

Enforce the requested QC, standardize the files, metadata, deviations and negative results, then return a complete evidence package to the researcher.

Workflow frontierWedge candidates / introduced one by one

01Perturbation transcriptomicsCandidate wedge

02CRISPR screensProtocol family

03Mass spectrometryMeasurement layer

04SequencingProven precedent

05Natural-product profilingLonger horizon

02 / Economies of coordination

Make the marginal experiment cheaper.

Cuvette does not own lab infrastructure. Scale comes from aggregating demand across researchers, reusing validated protocol definitions, routing each workflow to the right capacity, and learning from standardized returns.

The utility is not the building. It is the coordination layer that makes many buildings behave like one coherent system.

Aggregate demand

Bundle recurring experimental needs into clearer, steadier demand for specialized execution partners.

Route to the right partner

Match protocol requirements to capability, capacity and quality rather than forcing every workflow through one facility.

Reuse standardized protocols

Validated controls, schemas and QC rules can travel with the workflow instead of being rebuilt for every handoff.

Pass efficiency forward

As coordination improves, lower unit costs can widen access and reduce the R&D burden carried downstream to patients.

The wedge

Begin with one standardized, repeatable, high-value workflow—perturbation transcriptomics as a service is one candidate—then expand workflow by workflow as the quality layer earns trust.

03 / What becomes testable

Curiosity has always outrun infrastructure.

The most valuable starting points are often untidy: a soil sample, inherited knowledge, a field note. The utility exists to turn an observation into a careful experiment—without pretending the observation is already an answer.

01Rapa Nui
soil sample / 1964

Rapamycin

A soil sample collected during a 1964 expedition to Easter Island yielded Streptomyces hygroscopicus and, later, rapamycin. What began as an antimicrobial search became an immunosuppressant and a foundational tool for studying mTOR.

The lesson is not that serendipity replaces rigor. It is that infrastructure should make it easier to follow a strange signal wherever it leads.

CUVETTE QUESTION → How quickly could an unexpected phenotype be repeated, profiled and compared across a standardized assay family?

Historical review ↗

02Neem
natural product

Neem → nimbolide

Neem’s long medicinal history contains observations worth investigating—not conclusions to accept untested. Modern chemoproteomics found that nimbolide, a neem-derived natural product, covalently engages the E3 ligase RNF114 and opened a route into targeted protein degradation research.

CUVETTE QUESTION → Can inherited empirical knowledge enter a transparent, controlled validation pipeline without losing its context?

RNF114 research ↗

03Gabon
submitted field observation

The Gabon observation

Submitted hypothesis, not established fact. Field zoologist Fabian Schulz proposes that chimpanzee interactions with Omphalocarpum following wounds may warrant study. The observation and any biological effect remain unverified.

The value is in the disciplined next step: authenticate the sample, preserve provenance, identify its chemistry and test defined effects under controlled conditions.

CUVETTE QUESTION → What is present, and does any fraction change inflammation or healing in a reproducible assay?

Source status: submitted field observation; independent verification required.

04 / A model for fluid invention

When ideas are abundant, answers become the product.

AI makes conception faster and more fluid. In a world with weaker or different IP, value migrates away from owning the thought and toward coordinating reliable evidence—on time, at known quality, for a transparent price.

01 — Recover costs

Charge for execution.

Price the assay, partner capacity, materials, controls, orchestration and turnaround. The economic object is a trusted experiment—not a claim on the resulting idea.

02 — Compound learning

Keep protocols open.

Shared methods and structured negative results make the system improve with use. Data sharing can be governed explicitly rather than smuggled into the business model.

03 — Pass through scale

Lower the bill.

A coordination utility earns trust by improving throughput, reducing repeated work and making more lab capacity legible. The savings should widen access—and travel downstream to patients.

coordination ↑
cost / answer ↓

05 / A researcher, unretired

A serious lab, from the porch.

Wayne is a retired immunology pioneer in Sausalito. Treg biology is his life’s work. He has no physical lab, no institution behind him and not a single pipette. He still has the thing that matters: a hypothesis worth testing.

01 / Submit

The hypothesis

Wayne / Sausalito, California / running through cuvette.bio

He is still on the porch.

06 / The thesis

A postdoc in Nairobi should not need a sequencing core down the hall. A clinician should not need a venture round to test a pattern in patient biology. A retired immunologist’s best hypothesis should not disappear because the keycard expired.

When the marginal experiment gets cheaper, the strategy changes. You can test the unfashionable isoform. Run the negative control as its own investigation. Follow the observation from the forest, the archive or the family remedy—carefully, reproducibly, without pretending that an anecdote is already an answer.

Humans keep the one job machines can't do: choosing which question deserves the next well.

Execution can happen across a network. The protocol becomes portable code. The evidence comes back with a chain of custody.

The cost of curiosity should approach zero.

cuvette.bio

Request early access

Ask the question.The wet lab answers.